<DOC>
	<DOCNO>NCT01256424</DOCNO>
	<brief_summary>An effective safe medical therapy would welcome reduce need surgical intervention related adverse event psychological impact patient cervical cancer precursor . In clinical trial , investigator propose evaluate efficacy safety photodynamic therapy ( PDT ) use hexaminolevulinate ( HAL ) mild moderate-grade CIN ( grade 1-2 ) .</brief_summary>
	<brief_title>Dose-finding Study Hexaminolevulinate ( HAL ) Photodynamic Therapy ( PDT ) Treat Cervical Neoplasia</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<criteria>Patients ectocervical CIN1 CIN2 verify local pathology ( biopsy ) obtain within last month Satisfactory colposcopy examination include : visibility entire transformation zone include squamocolumnar junction visibility entire lesion margin Negative endocervical o colposcopy Colposcopical visible lesion visit 2 , treatment Patients average sized uterine cervix ( approximately 27mm diameter ) suitable application Klemcap Age 18 Written informed consent sign Previous treatment CIN invasive disease Lesion ( ) extend vaginal vault Atypical glandular cell ( AGC ) adenocarcinoma situ ( AIS ) cytology , malignant cell cytology histology suspicion either microinvasive invasive disease Suspicion endocervical disease colposcopy Current severe pelvic inflammatory disease , severe cervicitis , severe gynaecological infection per colposcopy clinical examination Undiagnosed vaginal bleeding History toxic shock syndrome Known suspect porphyria Known allergy hexaminolevulinate similar compound ( e.g . methyl aminolevulinate aminolevulinic acid ) Pregnancy , intention become pregnant study period Nursing Childbirth miscarriage within six week enrolment Use heart pacemaker Participation clinical study either concurrently within last 30 day Risk poor protocol compliance . Patient participation consider respect live far away hospital , plan move another city/state , frequent travelling , plan become pregnant , drug abuse/alcoholic , difficult working hour , family obligation , illness ( e.g . psychiatric ) , etc . Unwillingness use adequate birth control ( abstinence ) screen last PDT Patient investigator subinvestigator , research assistant , pharmacist , study coordinator , staff relative thereof directly involve conduct protocol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>CIN</keyword>
</DOC>